ConductScience.org, home

Paper19681102

Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA).

Zivin JA. Ann Neurol, 2009. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Papers, record 19681102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19681102

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA).
PubMed
Journal
Ann Neurol
PubMed
Year
2009
PubMed
Publication types
Historical Article, Journal Article
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
2.72
iCite
Revised in PubMed
2022-03-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zivin JAJustin A

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
StrokeMajor topic
Tissue Plasminogen ActivatorMajor topic
United States Food and Drug AdministrationMajor topic
Drug Approval
History, 20th Century
History, 21st Century
Humans
United States

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03519737Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic StrokeBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by63

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
42432671The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities.J Nanobiotechnology2026https://conductscience.org/library/papers/42432671PubMed
40143813PA System in the Pathogenesis of Ischemic Stroke.Arterioscler Thromb Vasc Biol2025https://conductscience.org/library/papers/40143813PubMed
38487357Thrombolytic Therapy for Central Retinal Artery Occlusion in an Academic Multi-Site Stroke Centre.Neuroophthalmology2024https://conductscience.org/library/papers/38487357PubMed
38424568Evaluating the effects of simulation training on stroke thrombolysis: a systematic review and meta-analysis.Adv Simul (Lond)2024https://conductscience.org/library/papers/38424568PubMed
38371456Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke.Int J Nanomedicine2024https://conductscience.org/library/papers/38371456PubMed
38317779Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends.Neurophotonics2024https://conductscience.org/library/papers/38317779PubMed
38030932Novel Programmed Death Ligand 1-AKT-engineered Mesenchymal Stem Cells Promote Neuroplasticity to Target Stroke Therapy.Mol Neurobiol2024https://conductscience.org/library/papers/38030932PubMed
37765291The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke.Pharmaceutics2023https://conductscience.org/library/papers/37765291PubMed
37443691Brain-Derived Neurotrophic Factor (BDNF) and Translocator Protein (TSPO) as Diagnostic Biomarkers for Acute Ischemic Stroke.Diagnostics (Basel)2023https://conductscience.org/library/papers/37443691PubMed
37326791Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion.Transl Stroke Res2024https://conductscience.org/library/papers/37326791PubMed
37289370The potential role of micro-RNA 125b-5p level in predicting outcome from thrombolytic therapy in patients with acute ischemic stroke.J Thromb Thrombolysis2023https://conductscience.org/library/papers/37289370PubMed
36714223Phenomic Studies on Diseases: Potential and Challenges.Phenomics2023https://conductscience.org/library/papers/36714223PubMed
35283994Brain-Derived Neurotrophic Factor and Nerve Growth Factor Therapeutics for Brain Injury: The Current Translational Challenges in Preclinical and Clinical Research.Neural Plast2022https://conductscience.org/library/papers/35283994PubMed
35281985
Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial.
Int J Prev Med2022https://conductscience.org/library/papers/35281985PubMed
35243774Potential nanotherapeutic strategies for perioperative stroke.CNS Neurosci Ther2022https://conductscience.org/library/papers/35243774PubMed
35218497Recycled Translation: Repurposing Drugs for Stroke.Transl Stroke Res2022https://conductscience.org/library/papers/35218497PubMed
35052603Prunus cerasoides Extract and Its Component Compounds Upregulate Neuronal Neuroglobin Levels, Mediate Antioxidant Effects, and Ameliorate Functional Losses in the Mouse Model of Cerebral Ischemia.Antioxidants (Basel)2021https://conductscience.org/library/papers/35052603PubMed
33830432The use of recombinant tissue plasminogen activator in in acute ischemic stroke is associated with increased level of BDNF.J Thromb Thrombolysis2021https://conductscience.org/library/papers/33830432PubMed
33730305Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.Cell Mol Neurobiol2022https://conductscience.org/library/papers/33730305PubMed
33707580Development of a photochemical thrombosis investigation system to obtain a rabbit ischemic stroke model.Sci Rep2021https://conductscience.org/library/papers/33707580PubMed

See all 63 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19681102

GET https://conductscience.org/api/papers/v1/19681102/cited_by?page=2